Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Plasma cell 1Other hematologic neoplasm 1Lymphoid 1Gynecologic 1Gastrointestinal 1CNS 1

Conditions

Uterine Neoplasms 1Sleep Wake Disorders 1Sleep Initiation and Maintenance Disorders 1Pancreatic Neoplasms 1Pain 1Ovarian Neoplasms 1Neoplasms 1Multiple Myeloma 1Lymphoma 1Lung Neoplasms 1Leukemia 1Glioblastoma 1Fatigue 1Esophageal Neoplasms 1Depression 1Anxiety Disorders 1

Interventions

Cyclophosphamide 447Rituximab 406Etoposide 225Vincristine 217Doxorubicin 204Filgrastim 201Prednisone 178Cytarabine 160Radiotherapy 152fludarabine phosphate 148Methotrexate 137Peripheral Blood Stem Cell Transplantation 130Melphalan 128fludarabine 116Busulfan 101Dexamethasone 93Tacrolimus 76Carmustine 74Granulocyte Colony-Stimulating Factor 73Mycophenolic Acid 72Gemcitabine 66Bortezomib 65Antilymphocyte Serum 65Whole-Body Irradiation 63Bendamustine Hydrochloride 63Lenalidomide 62Cyclosporine 62Ifosfamide 58sargramostim 51Methylprednisolone 49

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphoma × Uncertainty × Clear all
NCT01929720 2017-04-05

FOCUS

Ohio State University Comprehensive Cancer Center

Phase NA Completed
33 enrolled
CNSGastrointestinalGynecologicLymphoidOther hematologic neoplasmPlasma cellThoracic

Anxiety Disorders, Depression, Esophageal Neoplasms, Fatigue, Glioblastoma, Sleep Initiation and Maintenance Disorders, Leukemia, Lung Neoplasms, Lymphoma, Multiple Myeloma, Neoplasms, Ovarian Neoplasms, Pain, Pancreatic Neoplasms, Sleep Wake Disorders, Uterine Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡